Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Canopy Growth Corp T.WEED

Alternate Symbol(s):  T.WEED.DB | CGC

Healthcare Cannabis
Canopy Growth Corporation is a cannabis company. It delivers innovative products with a focus on premium and mainstream cannabis brands, including Doja, 7ACRES, Tweed, and Deep Space, in addition to category-defining vaporizer technology made in Germany by Storz & Bickel. The principal activities of the Company are the production, distribution and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. Its Canada cannabis segment includes the production, distribution, and sale of a range of cannabis, hemp, and cannabis related products in Canada. International markets cannabis segment includes the production, distribution, and sale of a range of cannabis and hemp products internationally. Storz & Bickel segment includes the production, distribution, and sale of vaporizers. This Works segment includes the production, distribution and sale of beauty, skincare, wellness and sleep products.


TSX:WEED - Post by User

Canopy Growth Corp > Data on cannabis for medical purposes
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(1286)
•••
Post by Tradinghandson Apr 30, 2024 8:37pm
149 Views
Post# 36016269

Data on cannabis for medical purposes

Data on cannabis for medical purposes

As you can see the medical cannabis in Canada is just a small declining percentage. Not being legal for recreation use leaves a void from the bigger usage market of recreational and by time anyone gets a Doctors note for it will be a year.

Data on medical client registrations

Highlights for the current update include:

  • The number of medical client registrations with federally licensed sellers fell 8% from 203,933 in June 2023 to 188,301 in September 2023.
  • The number of individuals registered with Health Canada for personal and designated cultivation of cannabis for their own medical purposes decreased 12% from 16,778 in June 2023 to 14,944 in September 2023.
  • The majority of the decrease of 1,834 in registrations for personal/designated production is from three Provinces: Ontario with a decrease of 608 registrations, British Columbia with 427 and Quebec with 347.
 

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities